Project Number 3R01AG071810-01S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator YOLES, ETI Principal Investigator First Name ETI Principal Investigator Last Name YOLES Awardee Organization IMMUNOBRAIN CHECKPOINT INC. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $250,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
